Purpose of the Analysis
- Determine eligibility for Tyrosine Kinase Inhibitors (TKIs).
- Identify targeted treatment options that precisely attack cancer cells.
- Monitor disease progression and detect any emerging resistance mutations.
Book EGFR Mutation Analysis in Saudi Arabia | Lahalak Medical Platform
The EGFR mutation analysis is a vital step in defining targeted therapy for lung cancer patients. It identifies specific genetic mutations to guide doctors toward the most effective personalized treatment plans.
Scientific name: EGFR Mutation Analysis Test
An advanced molecular test performed on tumor tissue biopsies to detect EGFR gene mutations. This analysis helps oncologists select the most effective targeted therapies, ensuring a personalized approach to cancer treatment.
Service type
Molecular Genetic Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood draw or biopsy submission
- Advanced molecular analysis
- Detailed medical report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Patients not responding to conventional therapies.
- Cases requiring precise genetic profiling before starting chemotherapy.
Frequently Asked Questions
- Is fasting required? No, fasting is not necessary for this test.
- How long do results take? Results typically take 7 to 10 working days due to the complexity of molecular testing.
Conditions & Notices
- Previous pathology report must be provided if a biopsy is used
Medical services you might also like
